Invention Grant
- Patent Title: Multivalent recombinant SPV
-
Application No.: US16307954Application Date: 2017-06-09
-
Publication No.: US11020472B2Publication Date: 2021-06-01
- Inventor: Takanori Sato , Shuji Saitoh , Yasutoshi Komiya
- Applicant: CEVA SANTE ANIMALE
- Applicant Address: FR Libourne
- Assignee: CEVA SANTE ANIMALE
- Current Assignee: CEVA SANTE ANIMALE
- Current Assignee Address: FR Libourne
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP16305697 20160610
- International Application: PCT/EP2017/064183 WO 20170609
- International Announcement: WO2017/212048 WO 20171214
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61P31/20 ; C12N15/86 ; A61K39/00
Abstract:
The present invention relates to novel recombinant swinepox viruses and their use in vaccine compositions. The recombinant swinepox viruses of the invention are doubly defective for IL18bp and TK genes, and comprise at least one foreign gene cloned into defective TK gene sequence. The invention is particularly suited to produce swine vaccines, particularly for vaccinating swine against PCV2 infection.
Public/Granted literature
- US20190307876A1 MULTIVALENT RECOMBINANT SPV Public/Granted day:2019-10-10
Information query
